KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cleanspark (CLSK) Cash & Equivalents (2016 - 2025)

Cleanspark (CLSK) has disclosed Cash & Equivalents for 16 consecutive years, with $43.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 65.43% to $43.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $43.0 million, a 65.43% decrease, with the full-year FY2025 number at $43.0 million, down 65.43% from a year prior.
  • Cash & Equivalents was $43.0 million for Q3 2025 at Cleanspark, up from $34.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $320.1 million in Q1 2024 to a low of $1.9 million in Q1 2022.
  • A 5-year average of $72.2 million and a median of $29.2 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 3389.94% in 2021, then crashed 98.78% in 2022.
  • Cleanspark's Cash & Equivalents stood at $5.2 million in 2021, then tumbled by 60.46% to $2.1 million in 2022, then soared by 2251.19% to $48.5 million in 2023, then skyrocketed by 477.83% to $280.0 million in 2024, then tumbled by 84.66% to $43.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLSK's Cash & Equivalents are $43.0 million (Q3 2025), $34.6 million (Q2 2025), and $100.4 million (Q1 2025).